1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIH Glycoscience Center of Research Excellence (GlyCORE) Funding is sponsored by National Institutes of Health (NIH) through University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE). This renewed grant funds glycoscience research at the University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE).
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) through University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
$10 Million NIH Grant Fuels Next Chapter for UM Glycoscience Research | Ole Miss Skip to main site navigation $10 Million NIH Grant Fuels Next Chapter for UM Glycoscience Research Five-year grant strengthens leadership in field, helping explore sugars' roles in health and disease $10 Million NIH Grant Fuels Next Chapter for UM Glycoscience Research OXFORD, Miss.
– The National Institutes of Health has awarded more than $10 million over the next five years to University of Mississippi's Glycoscience Center of Research Excellence. The money will fund research that could have broad impact on health and the treatment of diseases.
Glycoscience is the study of carbohydrates, or sugars, at the molecular level in the human body and how those molecules play an important role in almost every biological process, such as helping cells communicate and affecting immune system response. It connects chemistry, biology and medicine to help scientists better understand diseases and ultimately develop new treatments.
The UM School of Pharmacy established GlyCORE in 2020 with Phase 1 funding from NIH to support glycoscience research in the Mid-South. "We are incredibly proud of the leadership of Dr. (Joshua) Sharp and the entire GlyCORE team for bringing together talented researchers from across disciplines to tackle complex problems that impact human health," said Donna Strum, dean of the School of Pharmacy.
"This grant reflects the power of collaboration to truly advance discovery and drive innovation that will make a real difference." Ole Miss researchers plan to use the award to expand their expertise and build the center's research cores into a sustainable business model, said Joshua Sharp, director of GlyCORE, professor of pharmacology and joint professor of chemistry and biochemistry.
The initial funding of GlyCORE established three research cores of the organization: analytical and biophysical chemistry, imaging research, and computational chemistry and bioinformatics research. It also provided free support services for researchers in the fields. GlyCORE is not focused on a specific disease state or biomedical technology like other NIH Centers of biomedical research excellence, Sharp said.
"Rather, we bring together people from a wide variety of disciplines to support each other through the unique difficulties of studying these highly challenging, yet highly important, molecules," he explained. This allows GlyCORE to leverage the university's existing strengths such as natural products research and biomaterials with participants' interest in the field of glycoscience.
"This support helped many University of Mississippi faculty researchers establish national competitive programs in glycoscience that have led to external funding from the National Institutes of Health and National Science Foundation to further their research," he said. The new funding will support research project awards, which are three-year awards supporting new researchers.
Its pilot project awards will provide one year of funding to help researchers obtain preliminary data necessary to prove the usefulness of new research ideas. Paul Boudreau, assistant professor of pharmacognosy and research assistant professor in the Research Institute of Pharmaceutical Sciences , is among those whose research programs are supported by GlyCORE.
He is studying fat-like molecules called glycosphingolipids that are produced by some bacteria. Because some bacterial fats can activate the immune system, Boudreau's team hopes to determine whether the compounds could be useful as boosters to help vaccines work better by making the body's immune response stronger, he said.
"Additionally, GlyCORE support allowed me to recruit a new graduate student, Nathan Williams, who has joined the lab as a doctoral student," he said. GlyCORE has previously supported research ranging from exploring the link between stress and addiction and targeting breast cancer with sugar-coated particles to new cancer drug delivery methods , among other topics.
The center supports interdisciplinary glycoscience across a variety of departments and schools at Ole Miss, including pharmacy, engineering, chemistry and biology. It also hosts events such as its annual Mid-Science Glycoscience Meeting, Glycoscience Seminar Series and training workshops and classes. Participants from any department or discipline are welcome, Sharp said.
Researchers wishing to learn more or take advantage of the resources are encouraged to visit GlyCORE's website. "Ultimately, we seek to make the University of Mississippi internationally competitive in glycoscience, hosting multiple faculty members with extramural funding in glycoscience across a wide array of disciplines," Sharp said.
Top: GlyCORE has previously supported research at the university ranging from exploring the link between stress and addiction and targeting breast cancer with sugar-coated particles to new cancer drug delivery methods, among other topics. A new $10 million award from the National Institutes of Health promises to expand the work and help build the center's research cores into a sustainable business model.
Photo illustration by Stefanie Goodwiller/University marketing and Communications Office, Department or Center Glycoscience Center of Research Excellence
According to the current listing, eligibility includes: University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE) supports investigators at the University of Mississippi and the Mid-South community (including Mississippi, Alabama, Arkansas, Louisiana, …. Confirm the full requirements in the official notice before applying.
The current listing shows $10 million over five years (awarded October 2025). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH Glycoscience Center of Research Excellence (GlyCORE) Funding is funded by National Institutes of Health (NIH) through University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Mississippi, Louisiana, Arkansas, and Alabama. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NIH Glycoscience Center of Research Excellence (GlyCORE) - Research Project Program / Pilot Project Program is sponsored by National Institutes of Health (NIH) through University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE). This program, part of the University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE), supports investigators in glycoscience through direct funding of selected research projects and pilot projects.
GlyCORE: Glycoscience Center of Research Excellence - Research Project Program / Pilot Project Program is sponsored by National Institutes of Health (NIH) through University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE). This program, sponsored by NIH through the University of Mississippi's Glycoscience Center of Research Excellence (GlyCORE), provides direct funding for selected research projects and pilot projects in glycoscience.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleA single NIH policy notice threatened to strip $5.24 billion from research universities. Two courts blocked it. Congress weighed in. The fight is far from over.
Read articlePAR-26-042 funds NLM-priority clinical informatics R01 grants up to $250,000 in direct costs per year through March 6, 2029, with standard NIH cycles on October 5, February 5, and June 5. The notice explicitly defines non-responsive applications: incremental tool improvements, projects primarily focused on social determinants of health, and projects primarily focused on ethical/legal/social issues. With NIH SBIR/STTR just reopened and the OMB Uniform Grants Regulation rewrite reshaping discretionary awards, the NLM clinical informatics line is one of the few stable, well-defined biomedical funding streams left at the agency. Here is how to read it.
Read article